DLCIG
XPH icon

D.L. Carlson Investment Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

D.L. Carlson Investment Group’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,210
Closed -$287K – 158
2019
Q2 		$287K Sell
7,210
-2,040
-22% -$80.2K 0.09% 128
2019
Q1 		$385K Sell
9,250
-800
-8% -$32.5K 0.11% 115
2018
Q4 		$368K Buy
+10,050
New +$429K 0.12% 115

Other funds holding XPH

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

D.L. Carlson Investment Group's XPH Position: Q3 2019 in Review

D.L. Carlson Investment Group sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2019, closing a stake of 7,210 shares — an estimated $287K sold.

D.L. Carlson Investment Group first reported a position in XPH in Q4 2018 and held it in 3 quarters. The position peaked at $385K in Q1 2019. 60 funds tracked by Wall St. Rank hold XPH as of Q3 2019.

  • D.L. Carlson Investment Group reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2019 after selling out during the quarter.
  • D.L. Carlson Investment Group sold 7,210 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2019, an estimated $287K.
  • D.L. Carlson Investment Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2018 and held it in 3 quarters.
  • D.L. Carlson Investment Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $385K in Q1 2019.
  • 60 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2019.

Based on D.L. Carlson Investment Group's 13F filing for Q3 2019, filed 5 Nov 2019.